XY Capital’s Eli Lilly LLY Stock Holding History

XY Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-311	Closed	-$257K	–	127
2025 Q1	$257K	Buy	+311	New	+$259K	0.07%	161

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

XY Capital's LLY Position: Q2 2025 in Review

XY Capital sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 311 shares — an estimated $257K sold.

XY Capital first reported a position in LLY in Q1 2025 and held it in 1 quarter. The position peaked at $257K in Q1 2025. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

XY Capital reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
XY Capital sold 311 Eli Lilly shares in Q2 2025, an estimated $257K.
XY Capital first reported a position in Eli Lilly in Q1 2025 and held it in 1 quarter.
XY Capital's Eli Lilly position peaked at $257K in Q1 2025.
3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on XY Capital's 13F filing for Q2 2025, filed 14 Aug 2025.